Raising vitamin D intake could lower breast, colorectal cancer risk
Increasing the daily intake of vitamin D to 2000 International Units could halve the risk of developing breast and colorectal cancer, two studies have reported.
Increasing the daily intake of vitamin D to 2000 International Units could halve the risk of developing breast and colorectal cancer, two studies have reported.
An American Journal of Clinical Nutrition article, based on last year's NIH State of the Science conference, has suggested that building scientific standards into supplements legislation could be a way to reward companies making science-based marketing.
Oat products with a higher fat content could be eligible to carry a heart health claim, according to a new proposal by the US Food and Drug Administration (FDA).
ReGen Therapeutics is today issuing over 150m new shares to raise £1.1m, in part to fund ongoing development of its Colostrinin nutraceutical that is expected to be commercialised this year.
A range of functional ingredients solutions has been launched by Tate & Lyle, as it looks to capitalise on consumer demand for healthy yoghurts and dairy drinks.
A diet rich in the plant omega-3 alpha-linolenic acid (ALA) reduced blood pressure by up to six per cent, says new research from Greece.
A new report from Business Insights is turning the spotlight on science to support the efficacy of healthy ingredients, a preoccupation for food and drink manufacturers in the present climate of shifting health claims regulations.
Dietary supplements marketer Herbalife received a $38-a-share offer from private-equity firm Whitney & Company - who already own 27 percent of its stock - and Monday the company's shares had already inched up to $40.12.